Global Dementia Treatment Market By Indication (Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia, Parkinson Disease Dementia, and Others), By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonist, MAO Inhibitors, Combination Drug, and Others), By Route of Administration (Oral, Transdermal Patch, and Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Dec 2024
- Report ID: 135745
- Number of Pages: 355
- Format:
-
-
- 1. Executive Summary
- 1.1. Definition
- 1.2. Market Snapshot
- 1.3. Market Overview
- 1.4. Segment Overview
- 1.5. Regional Overview
- 1.6. Competitive Landscape
- 1.7. Taxonomy
- 2. Global Market Overview
- 2.1. Global Market Insights and Industry Overview
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunities
- 2.2.4. Key Dementia Treatment Market Trends
- 2.3. Regulatory Framework
- 2.4. Opportunity Map Analysis
- 2.5. Opportunity Orbits
- 2.6. PESTLE Analysis
- 2.7. PORTER’S Five Force Analysis
- 2.8. Drivers & Restraints Impact Analysis
- 2.9. Value Chain Analysis
- 2.9.1. List of Raw Materials Suppliers
- 2.9.2. List of Dementia Treatment Manufacturers
- 2.9.3. List of Dealer/Distributors
- 2.10. Regional Market Share and BPS Analysis
- 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Dementia Treatment Market Analysis and Forecast, By Segment, 2019-2033
- 3.1. Key Findings
- 3.2. Global Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
- 3.3. Global Dementia Treatment Market Attractiveness Analysis, By Indication
- 3.3.1. Alzheimer’s Disease Dementia
- 3.3.1.1. Insights
- 3.3.1.2. Key Takeaways
- 3.3.2. Vascular Dementia
- 3.3.2.1. Insights
- 3.3.2.2. Key Takeaways
- 3.3.3. Lewy Body Dementia
- 3.3.3.1. Insights
- 3.3.3.2. Key Takeaways
- 3.3.4. Frontotemporal Dementia (FTD)
- 3.3.4.1. Insights
- 3.3.4.2. Key Takeaways
- 3.3.5. Parkinson Disease Dementia
- 3.3.5.1. Insights
- 3.3.5.2. Key Takeaways
- 3.3.6. Others
- 3.3.6.1. Insights
- 3.3.6.2. Key Takeaways
- 3.3.1. Alzheimer’s Disease Dementia
- 3.4. Global Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 3.5. Global Dementia Treatment Market Attractiveness Analysis, By Drug Class
- 3.5.1. Cholinesterase Inhibitors
- 3.5.1.1. Insights
- 3.5.1.2. Key Takeaways
- 3.5.2. NMDA Receptor Antagonist
- 3.5.2.1. Insights
- 3.5.2.2. Key Takeaways
- 3.5.3. MAO Inhibitors
- 3.5.3.1. Insights
- 3.5.3.2. Key Takeaways
- 3.5.4. Combination Drug
- 3.5.4.1. Insights
- 3.5.4.2. Key Takeaways
- 3.5.5. Others
- 3.5.5.1. Insights
- 3.5.5.2. Key Takeaways
- 3.5.1. Cholinesterase Inhibitors
- 3.6. Global Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 3.7. Global Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- 3.7.1. Oral
- 3.7.1.1. Insights
- 3.7.1.2. Key Takeaways
- 3.7.2. Transdermal Patch
- 3.7.2.1. Insights
- 3.7.2.2. Key Takeaways
- 3.7.3. Injectable
- 3.7.3.1. Insights
- 3.7.3.2. Key Takeaways
- 3.7.1. Oral
- 3.8. Global Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 3.9. Global Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- 3.9.1. Hospital Pharmacy
- 3.9.1.1. Insights
- 3.9.1.2. Key Takeaways
- 3.9.2. Retail Pharmacy
- 3.9.2.1. Insights
- 3.9.2.2. Key Takeaways
- 3.9.3. Online Pharmacy
- 3.9.3.1. Insights
- 3.9.3.2. Key Takeaways
- 3.9.1. Hospital Pharmacy
- 4. Global Dementia Treatment Market Analysis and Forecast, By Region, 2019-2033
- 4.1. Key Findings
- 4.2. Global Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
- 4.2.1. North America
- 4.2.1.1. Regional Insights
- 4.2.2. Europe
- 4.2.2.1. Regional Insights
- 4.2.3. Asia Pacific
- 4.2.3.1. Regional Insights
- 4.2.4. Latin America
- 4.2.4.1. Regional Insights
- 4.2.5. Middle East & Africa
- 4.2.5.1. Regional Insights
- 4.2.1. North America
- 4.3. Global Dementia Treatment Market Attractiveness Analysis, By Region
- 5. North America Dementia Treatment Market Analysis and Forecast, 2019-2033
- 5.1. Key Findings
- 5.2. North America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
- 5.3. North America Dementia Treatment Market Attractiveness Analysis, By Indication
- 5.4. North America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 5.5. North America Dementia Treatment Market Attractiveness Analysis, By Drug Class
- 5.6. North America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 5.7. North America Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- 5.8. North America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 5.9. North America Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- 5.10. North America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 5.11. North America Dementia Treatment Market Attractiveness Analysis, By Country
- 5.11.1. The US
- 5.11.2. Canada
- 6. Europe Dementia Treatment Market Analysis and Forecast, 2019-2033
- 6.1. Key Findings
- 6.2. Europe Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
- 6.3. Europe Dementia Treatment Market Attractiveness Analysis, By Indication
- 6.4. Europe Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 6.5. Europe Dementia Treatment Market Attractiveness Analysis, By Drug Class
- 6.6. Europe Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 6.7. Europe Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- 6.8. Europe Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 6.9. Europe Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- 6.10. Europe Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 6.11. Europe Dementia Treatment Market Attractiveness Analysis, By Country
- 6.11.1. Germany
- 6.11.2. The UK
- 6.11.3. France
- 6.11.4. Spain
- 6.11.5. Italy
- 6.11.6. Russia
- 6.11.7. Netherland
- 6.11.8. Rest of Europe
- 7. Asia Pacific Dementia Treatment Market Analysis and Forecast, 2019-2033
- 7.1. Key Findings
- 7.2. Asia Pacific Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
- 7.3. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Indication
- 7.4. Asia Pacific Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 7.5. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Drug Class
- 7.6. Asia Pacific Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 7.7. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- 7.8. Asia Pacific Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 7.9. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- 7.10. Asia Pacific Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 7.11. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Country
- 7.11.1. China
- 7.11.2. Japan
- 7.11.3. South Korea
- 7.11.4. India
- 7.11.5. Australia
- 7.11.6. New Zealand
- 7.11.7. Singapore
- 7.11.8. Thailand
- 7.11.9. Vietnam
- 7.11.10. Rest of Asia Pacific
- 8. Latin America Dementia Treatment Market Analysis and Forecast, 2019-2033
- 8.1. Key Findings
- 8.2. Latin America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
- 8.3. Latin America Dementia Treatment Market Attractiveness Analysis, By Indication
- 8.4. Latin America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 8.5. Latin America Dementia Treatment Market Attractiveness Analysis, By Drug Class
- 8.6. Latin America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 8.7. Latin America Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- 8.8. Latin America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 8.9. Latin America Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- 8.10. Latin America Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 8.11. Latin America Dementia Treatment Market Attractiveness Analysis, By Country
- 8.11.1. Brazil
- 8.11.2. Mexico
- 8.11.3. Rest of Latin America
- 9. Middle East & Africa Dementia Treatment Market Analysis and Forecast, 2019-2033
- 9.1. Key Findings
- 9.2. Middle East & Africa Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
- 9.3. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Indication
- 9.4. Middle East & Africa Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
- 9.5. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Drug Class
- 9.6. Middle East & Africa Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
- 9.7. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- 9.8. Middle East & Africa Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
- 9.9. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- 9.10. Middle East & Africa Dementia Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 9.11. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Country
- 9.11.1. South Africa
- 9.11.2. Saudi Arabia
- 9.11.3. UAE
- 9.11.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
- 10.1. Market Competition Scenario Analysis, By Company
- 10.1.1. Key Takeaways
- 10.2. Overview of Major Market Players
- 10.3. Competitor Landscape
- 10.4. Strategic Mapping
- 10.5. Company Life Cycle Analysis
- 10.6. Company Market Share Analysis
- 10.7. Company Profiles
- 10.7.1. Eisai Co., Ltd.
- 10.7.1.1. Company Details
- 10.7.1.2. Business Overview
- 10.7.1.3. Product Portfolio
- 10.7.1.4. Financial Insights
- 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.1.6. SWOT Analysis
- 10.7.1.7. Geographic Footprint
- 10.7.2. Eli Lilly and Co
- 10.7.2.1. Company Details
- 10.7.2.2. Business Overview
- 10.7.2.3. Product Portfolio
- 10.7.2.4. Financial Insights
- 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.2.6. SWOT Analysis
- 10.7.2.7. Geographic Footprint
- 10.7.3. Novartis AG
- 10.7.3.1. Company Details
- 10.7.3.2. Business Overview
- 10.7.3.3. Product Portfolio
- 10.7.3.4. Financial Insights
- 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.3.6. SWOT Analysis
- 10.7.3.7. Geographic Footprint
- 10.7.4. Daiichi Sankyo Company, Ltd.
- 10.7.4.1. Company Details
- 10.7.4.2. Business Overview
- 10.7.4.3. Product Portfolio
- 10.7.4.4. Financial Insights
- 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.4.6. SWOT Analysis
- 10.7.4.7. Geographic Footprint
- 10.7.5. AbbVie Inc.
- 10.7.5.1. Company Details
- 10.7.5.2. Business Overview
- 10.7.5.3. Product Portfolio
- 10.7.5.4. Financial Insights
- 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.5.6. SWOT Analysis
- 10.7.5.7. Geographic Footprint
- 10.7.6. H. Lundbeck A/S
- 10.7.6.1. Company Details
- 10.7.6.2. Business Overview
- 10.7.6.3. Product Portfolio
- 10.7.6.4. Financial Insights
- 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.6.6. SWOT Analysis
- 10.7.6.7. Geographic Footprint
- 10.7.7. Biogen
- 10.7.7.1. Company Details
- 10.7.7.2. Business Overview
- 10.7.7.3. Product Portfolio
- 10.7.7.4. Financial Insights
- 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.7.6. SWOT Analysis
- 10.7.7.7. Geographic Footprint
- 10.7.8. Cipla Inc.
- 10.7.8.1. Company Details
- 10.7.8.2. Business Overview
- 10.7.8.3. Product Portfolio
- 10.7.8.4. Financial Insights
- 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.8.6. SWOT Analysis
- 10.7.8.7. Geographic Footprint
- 10.7.9. Sun Pharmaceutical Industries Ltd.
- 10.7.9.1. Company Details
- 10.7.9.2. Business Overview
- 10.7.9.3. Product Portfolio
- 10.7.9.4. Financial Insights
- 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.9.6. SWOT Analysis
- 10.7.9.7. Geographic Footprint
- 10.7.10. Viatris Inc.
- 10.7.10.1. Company Details
- 10.7.10.2. Business Overview
- 10.7.10.3. Product Portfolio
- 10.7.10.4. Financial Insights
- 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.10.6. SWOT Analysis
- 10.7.10.7. Geographic Footprint
- 10.7.1. Eisai Co., Ltd.
- 10.1. Market Competition Scenario Analysis, By Company
- 11. Methodology and Data Source
- 11.1. Methodology/Research Approach
- 11.2. Market Size Estimation
- 11.3. Market Breakdown and Data Triangulation
- 11.4. Data Source
- 11.5. Secondary Sources
- 11.6. Primary Sources
- 11.7. Appendix
- 11.8. Disclaimer
- List of Tables
- Table 1. Global Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 2. Global Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 3. Global Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 4. Global Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 5. Global Dementia Treatment Market Value (US$ Mn), By Region, 2019-2033
- Table 6. North America Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 7. North America Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 8. North America Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 9. North America Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 10. North America Dementia Treatment Market Value (US$ Mn), By Country, 2019-2033
- Table 11. The US Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 12. The US Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 13. The US Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 14. The US Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 15. Canada Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 16. Canada Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 17. Canada Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 18. Canada Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 19. Europe Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 20. Europe Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 21. Europe Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 22. Europe Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 23. Europe Dementia Treatment Market Value (US$ Mn), By Country, 2019-2033
- Table 24. Germany Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 25. Germany Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 26. Germany Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 27. Germany Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 28. The UK Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 29. The UK Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 30. The UK Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 31. The UK Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 32. France Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 33. France Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 34. France Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 35. France Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 36. Spain Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 37. Spain Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 38. Spain Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 39. Spain Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 40. Italy Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 41. Italy Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 42. Italy Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 43. Italy Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 44. Russia Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 45. Russia Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 46. Russia Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 47. Russia Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 48. Netherland Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 49. Netherland Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 50. Netherland Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 51. Netherland Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 52. Rest of Europe Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 53. Rest of Europe Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 54. Rest of Europe Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 55. Rest of Europe Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 56. Asia Pacific Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 57. Asia Pacific Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 58. Asia Pacific Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 59. Asia Pacific Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 60. Asia Pacific Dementia Treatment Market Value (US$ Mn), By Country, 2019-2033
- Table 61. China Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 62. China Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 63. China Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 64. China Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 65. India Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 66. India Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 67. India Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 68. India Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 69. Japan Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 70. Japan Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 71. Japan Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 72. Japan Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 73. South Korea Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 74. South Korea Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 75. South Korea Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 76. South Korea Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 77. Australia Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 78. Australia Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 79. Australia Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 80. Australia Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 81. New Zealand Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 82. New Zealand Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 83. New Zealand Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 84. New Zealand Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 85. Singapore Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 86. Singapore Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 87. Singapore Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 88. Singapore Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 89. Thailand Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 90. Thailand Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 91. Thailand Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 92. Thailand Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 93. Vietnam Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 94. Vietnam Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 95. Vietnam Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 96. Vietnam Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 97. Rest of Asia Pacific Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 98. Rest of Asia Pacific Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 99. Rest of Asia Pacific Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 100. Rest of Asia Pacific Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 101. Latin America Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 102. Latin America Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 103. Latin America Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 104. Latin America Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 105. Latin America Dementia Treatment Market Value (US$ Mn), By Country, 2019-2033
- Table 106. Brazil Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 107. Brazil Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 108. Brazil Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 109. Brazil Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 110. Mexico Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 111. Mexico Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 112. Mexico Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 113. Mexico Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 114. Rest of Latin America Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 115. Rest of Latin America Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 116. Rest of Latin America Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 117. Rest of Latin America Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 118. Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 119. Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 120. Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 121. Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 122. Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Country, 2019-2033
- Table 123. South Africa Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 124. South Africa Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 125. South Africa Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 126. South Africa Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 127. Saudi Arabia Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 128. Saudi Arabia Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 129. Saudi Arabia Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 130. Saudi Arabia Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 131. UAE Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 132. UAE Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 133. UAE Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 134. UAE Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- Table 135. Rest of Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Indication, 2019-2033
- Table 136. Rest of Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Drug Class, 2019-2033
- Table 137. Rest of Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Route of Administration, 2019-2033
- Table 138. Rest of Middle East & Africa Dementia Treatment Market Value (US$ Mn), By Distribution Channel, 2019-2033
- List of Figures
- Figure 1. Global Dementia Treatment Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Dementia Treatment Market
- Figure 5. Global Dementia Treatment Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 6. Global Dementia Treatment Market Attractiveness Analysis, By Indication
- Figure 7. Global Dementia Treatment Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 8. Global Dementia Treatment Market Attractiveness Analysis, By Drug Class
- Figure 9. Global Dementia Treatment Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 10. Global Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 11. Global Dementia Treatment Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 12. Global Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 13. Global Dementia Treatment Market Analysis, By Region, 2019, 2023 and 2033
- Figure 14. Global Dementia Treatment Market Attractiveness Analysis, By Region
- Figure 15. North America Dementia Treatment Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 16. North America Dementia Treatment Market Attractiveness Analysis, By Indication
- Figure 17. North America Dementia Treatment Market (US$ Mn), by Alzheimer’s Disease Dementia, 2019-2033
- Figure 18. North America Dementia Treatment Market (US$ Mn), by Vascular Dementia, 2019-2033
- Figure 19. North America Dementia Treatment Market (US$ Mn), by Lewy Body Dementia, 2019-2033
- Figure 20. North America Dementia Treatment Market (US$ Mn), by Frontotemporal Dementia (FTD), 2019-2033
- Figure 21. North America Dementia Treatment Market (US$ Mn), by Parkinson Disease Dementia, 2019-2033
- Figure 22. North America Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 23. North America Dementia Treatment Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 24. North America Dementia Treatment Market Attractiveness Analysis, By Drug Class
- Figure 25. North America Dementia Treatment Market (US$ Mn), by Cholinesterase Inhibitors, 2019-2033
- Figure 26. North America Dementia Treatment Market (US$ Mn), by NMDA Receptor Antagonist, 2019-2033
- Figure 27. North America Dementia Treatment Market (US$ Mn), by MAO Inhibitors, 2019-2033
- Figure 28. North America Dementia Treatment Market (US$ Mn), by Combination Drug, 2019-2033
- Figure 29. North America Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 30. North America Dementia Treatment Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 31. North America Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 32. North America Dementia Treatment Market (US$ Mn), by Oral, 2019-2033
- Figure 33. North America Dementia Treatment Market (US$ Mn), by Transdermal Patch, 2019-2033
- Figure 34. North America Dementia Treatment Market (US$ Mn), by Injectable, 2019-2033
- Figure 35. North America Dementia Treatment Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 36. North America Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 37. North America Dementia Treatment Market (US$ Mn), by Hospital Pharmacy, 2019-2033
- Figure 38. North America Dementia Treatment Market (US$ Mn), by Retail Pharmacy, 2019-2033
- Figure 39. North America Dementia Treatment Market (US$ Mn), by Online Pharmacy, 2019-2033
- Figure 40. North America Dementia Treatment Market Analysis, By Country, 2019, 2023 and 2033
- Figure 41. North America Dementia Treatment Market Attractiveness Analysis, By Country
- Figure 42. Europe Dementia Treatment Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 43. Europe Dementia Treatment Market Attractiveness Analysis, By Indication
- Figure 44. Europe Dementia Treatment Market (US$ Mn), by Alzheimer’s Disease Dementia, 2019-2033
- Figure 45. Europe Dementia Treatment Market (US$ Mn), by Vascular Dementia, 2019-2033
- Figure 46. Europe Dementia Treatment Market (US$ Mn), by Lewy Body Dementia, 2019-2033
- Figure 47. Europe Dementia Treatment Market (US$ Mn), by Frontotemporal Dementia (FTD), 2019-2033
- Figure 48. Europe Dementia Treatment Market (US$ Mn), by Parkinson Disease Dementia, 2019-2033
- Figure 49. Europe Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 50. Europe Dementia Treatment Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 51. Europe Dementia Treatment Market Attractiveness Analysis, By Drug Class
- Figure 52. Europe Dementia Treatment Market (US$ Mn), by Cholinesterase Inhibitors, 2019-2033
- Figure 53. Europe Dementia Treatment Market (US$ Mn), by NMDA Receptor Antagonist, 2019-2033
- Figure 54. Europe Dementia Treatment Market (US$ Mn), by MAO Inhibitors, 2019-2033
- Figure 55. Europe Dementia Treatment Market (US$ Mn), by Combination Drug, 2019-2033
- Figure 56. Europe Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 57. Europe Dementia Treatment Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 58. Europe Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 59. Europe Dementia Treatment Market (US$ Mn), by Oral, 2019-2033
- Figure 60. Europe Dementia Treatment Market (US$ Mn), by Transdermal Patch, 2019-2033
- Figure 61. Europe Dementia Treatment Market (US$ Mn), by Injectable, 2019-2033
- Figure 62. Europe Dementia Treatment Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 63. Europe Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 64. Europe Dementia Treatment Market (US$ Mn), by Hospital Pharmacy, 2019-2033
- Figure 65. Europe Dementia Treatment Market (US$ Mn), by Retail Pharmacy, 2019-2033
- Figure 66. Europe Dementia Treatment Market (US$ Mn), by Online Pharmacy, 2019-2033
- Figure 67. Europe Dementia Treatment Market Analysis, By Country, 2019, 2023 and 2033
- Figure 68. Europe Dementia Treatment Market Attractiveness Analysis, By Country
- Figure 69. Asia Pacific Dementia Treatment Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 70. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Indication
- Figure 71. Asia Pacific Dementia Treatment Market (US$ Mn), by Alzheimer’s Disease Dementia, 2019-2033
- Figure 72. Asia Pacific Dementia Treatment Market (US$ Mn), by Vascular Dementia, 2019-2033
- Figure 73. Asia Pacific Dementia Treatment Market (US$ Mn), by Lewy Body Dementia, 2019-2033
- Figure 74. Asia Pacific Dementia Treatment Market (US$ Mn), by Frontotemporal Dementia (FTD), 2019-2033
- Figure 75. Asia Pacific Dementia Treatment Market (US$ Mn), by Parkinson Disease Dementia, 2019-2033
- Figure 76. Asia Pacific Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 77. Asia Pacific Dementia Treatment Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 78. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Drug Class
- Figure 79. Asia Pacific Dementia Treatment Market (US$ Mn), by Cholinesterase Inhibitors, 2019-2033
- Figure 80. Asia Pacific Dementia Treatment Market (US$ Mn), by NMDA Receptor Antagonist, 2019-2033
- Figure 81. Asia Pacific Dementia Treatment Market (US$ Mn), by MAO Inhibitors, 2019-2033
- Figure 82. Asia Pacific Dementia Treatment Market (US$ Mn), by Combination Drug, 2019-2033
- Figure 83. Asia Pacific Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 84. Asia Pacific Dementia Treatment Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 85. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 86. Asia Pacific Dementia Treatment Market (US$ Mn), by Oral, 2019-2033
- Figure 87. Asia Pacific Dementia Treatment Market (US$ Mn), by Transdermal Patch, 2019-2033
- Figure 88. Asia Pacific Dementia Treatment Market (US$ Mn), by Injectable, 2019-2033
- Figure 89. Asia Pacific Dementia Treatment Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 90. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 91. Asia Pacific Dementia Treatment Market (US$ Mn), by Hospital Pharmacy, 2019-2033
- Figure 92. Asia Pacific Dementia Treatment Market (US$ Mn), by Retail Pharmacy, 2019-2033
- Figure 93. Asia Pacific Dementia Treatment Market (US$ Mn), by Online Pharmacy, 2019-2033
- Figure 94. Asia Pacific Dementia Treatment Market Analysis, By Country, 2019, 2023 and 2033
- Figure 95. Asia Pacific Dementia Treatment Market Attractiveness Analysis, By Country
- Figure 96. Latin America Dementia Treatment Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 97. Latin America Dementia Treatment Market Attractiveness Analysis, By Indication
- Figure 98. Latin America Dementia Treatment Market (US$ Mn), by Alzheimer’s Disease Dementia, 2019-2033
- Figure 99. Latin America Dementia Treatment Market (US$ Mn), by Vascular Dementia, 2019-2033
- Figure 100. Latin America Dementia Treatment Market (US$ Mn), by Lewy Body Dementia, 2019-2033
- Figure 101. Latin America Dementia Treatment Market (US$ Mn), by Frontotemporal Dementia (FTD), 2019-2033
- Figure 102. Latin America Dementia Treatment Market (US$ Mn), by Parkinson Disease Dementia, 2019-2033
- Figure 103. Latin America Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 104. Latin America Dementia Treatment Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 105. Latin America Dementia Treatment Market Attractiveness Analysis, By Drug Class
- Figure 106. Latin America Dementia Treatment Market (US$ Mn), by Cholinesterase Inhibitors, 2019-2033
- Figure 107. Latin America Dementia Treatment Market (US$ Mn), by NMDA Receptor Antagonist, 2019-2033
- Figure 108. Latin America Dementia Treatment Market (US$ Mn), by MAO Inhibitors, 2019-2033
- Figure 109. Latin America Dementia Treatment Market (US$ Mn), by Combination Drug, 2019-2033
- Figure 110. Latin America Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 111. Latin America Dementia Treatment Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 112. Latin America Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 113. Latin America Dementia Treatment Market (US$ Mn), by Oral, 2019-2033
- Figure 114. Latin America Dementia Treatment Market (US$ Mn), by Transdermal Patch, 2019-2033
- Figure 115. Latin America Dementia Treatment Market (US$ Mn), by Injectable, 2019-2033
- Figure 116. Latin America Dementia Treatment Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 117. Latin America Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 118. Latin America Dementia Treatment Market (US$ Mn), by Hospital Pharmacy, 2019-2033
- Figure 119. Latin America Dementia Treatment Market (US$ Mn), by Retail Pharmacy, 2019-2033
- Figure 120. Latin America Dementia Treatment Market (US$ Mn), by Online Pharmacy, 2019-2033
- Figure 121. Latin America Dementia Treatment Market Analysis, By Country, 2019, 2023 and 2033
- Figure 122. Latin America Dementia Treatment Market Attractiveness Analysis, By Country
- Figure 123. Middle East & Africa Dementia Treatment Market Analysis, By Indication, 2019, 2023 and 2033
- Figure 124. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Indication
- Figure 125. Middle East & Africa Dementia Treatment Market (US$ Mn), by Alzheimer’s Disease Dementia, 2019-2033
- Figure 126. Middle East & Africa Dementia Treatment Market (US$ Mn), by Vascular Dementia, 2019-2033
- Figure 127. Middle East & Africa Dementia Treatment Market (US$ Mn), by Lewy Body Dementia, 2019-2033
- Figure 128. Middle East & Africa Dementia Treatment Market (US$ Mn), by Frontotemporal Dementia (FTD), 2019-2033
- Figure 129. Middle East & Africa Dementia Treatment Market (US$ Mn), by Parkinson Disease Dementia, 2019-2033
- Figure 130. Middle East & Africa Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 131. Middle East & Africa Dementia Treatment Market Analysis, By Drug Class, 2019, 2023 and 2033
- Figure 132. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Drug Class
- Figure 133. Middle East & Africa Dementia Treatment Market (US$ Mn), by Cholinesterase Inhibitors, 2019-2033
- Figure 134. Middle East & Africa Dementia Treatment Market (US$ Mn), by NMDA Receptor Antagonist, 2019-2033
- Figure 135. Middle East & Africa Dementia Treatment Market (US$ Mn), by MAO Inhibitors, 2019-2033
- Figure 136. Middle East & Africa Dementia Treatment Market (US$ Mn), by Combination Drug, 2019-2033
- Figure 137. Middle East & Africa Dementia Treatment Market (US$ Mn), by Others, 2019-2033
- Figure 138. Middle East & Africa Dementia Treatment Market Analysis, By Route of Administration, 2019, 2023 and 2033
- Figure 139. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Route of Administration
- Figure 140. Middle East & Africa Dementia Treatment Market (US$ Mn), by Oral, 2019-2033
- Figure 141. Middle East & Africa Dementia Treatment Market (US$ Mn), by Transdermal Patch, 2019-2033
- Figure 142. Middle East & Africa Dementia Treatment Market (US$ Mn), by Injectable, 2019-2033
- Figure 143. Middle East & Africa Dementia Treatment Market Analysis, By Distribution Channel, 2019, 2023 and 2033
- Figure 144. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Distribution Channel
- Figure 145. Middle East & Africa Dementia Treatment Market (US$ Mn), by Hospital Pharmacy, 2019-2033
- Figure 146. Middle East & Africa Dementia Treatment Market (US$ Mn), by Retail Pharmacy, 2019-2033
- Figure 147. Middle East & Africa Dementia Treatment Market (US$ Mn), by Online Pharmacy, 2019-2033
- Figure 148. Middle East & Africa Dementia Treatment Market Analysis, By Country, 2019, 2023 and 2033
- Figure 149. Middle East & Africa Dementia Treatment Market Attractiveness Analysis, By Country
- 1. Executive Summary
-
- Eisai Co. Ltd.
- Eli Lilly and Co
- Novartis AG Company Profile
- Daiichi Sankyo Company Ltd.
- AbbVie Inc. Company Profile
- Lundbeck A/S
- Biogen
- Cipla Inc.
- Sun Pharmaceutical Industries Ltd.
- Viatris Inc.
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Kickstart 2025 with Exclusive Savings
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |